Try our mobile app
Screener
Company
Price and
change
Revenue Growth
last / hist
EV /
LTM
EBITDA
(p75)
EV/
Sales
EBITDA LTM
/ Revenue
FCF LTM
/ Revenue
Next GAAP report
Year div-d yield
FCF Yield LTM
200.0%  /
160.6%
0.6x
0.9x
0.3x
48.3%
-32.8%
..
0.0%
-268.2% 
0.0%  /
83.2%
2.4x
3.1x
1x
39.1%
2.9%
..
0.0%
9.1% 
84.9%  /
78.5%
3.3x
3.4x
2.2x
65.8%
-39.4%
2025-07-29
0.5%
-31.3% 
53.1%  /
48.6%
1.6x
2.8x
0.9x
53.7%
3457.3%
..
0.3%
6 640.4% 
80.5%  /
42.4%
2.9x
3.2x
1.9x
64.4%
24.6%
2025-08-06
7.7%
20.4% 
85.5%  /
42.0%
5.7x
5.1x
3.7x
65.6%
-26.1%
2025-08-05
6.5%
-12.3% 
111.0%  /
39.3%
5.6x
6.2x
3.6x
64.8%
-43.4%
2025-07-31
4.7%
-33.5% 
34.2%  /
39.2%
3.2x
3.9x
0.5x
15.8%
2.5%
2025-08-12
7.0%
9.5% 
32.7%  /
31.7%
3.4x
3x
2.4x
71.5%
73.7%
2025-08-04
3.6%
36.2% 
19.1%  /
30.5%
3.1x
1.8x
2.3x
76.1%
-91.4%
2025-08-06
3.6%
-55.3% 
200.0%  /
26.8%
18.3x
20.7x
5.1x
27.7%
-304.7%
2025-07-30
6.5%
-270.5% 
-71.4%  /
24.2%
5.9x
20.9x
3.3x
56.0%
20.2%
..
9.4%
16.2% 
23.8%  /
23.8%
3.9x
4x
2.7x
68.3%
52.6%
2025-07-29
4.8%
36.3% 
28.5%  /
17.2%
1.6x
1.7x
0.6x
37.1%
3.2%
..
51.8%
17.4% 
176.5%  /
14.0%
2.9x
2.9x
1.5x
50.8%
53.8%
..
0.0%
25.8% 
59.6%  /
8.5%
3.7x
5x
1.9x
51.3%
-12.0%
2025-07-30
6.6%
-19.9% 
10.4%  /
7.0%
5.6x
5.6x
2x
35.8%
74.2%
..
0.0%
890.2% 
-35.7%  /
-1.2%
15.5x
4.9x
0.6x
16.1%
0.0%
2025-08-07
0.0%
--- 
8.3%  /
-3.7%
6.1x
9.9x
1.3x
21.6%
5.8%
2025-07-31
1.3%
4.6% 
-42.5%  /
-4.4%
8.8x
9.2x
3.5x
40.0%
-2.9%
..
9.4%
-1.5% 
-39.3%  /
-11.2%
6.1x
9.2x
2x
33.0%
11.7%
2025-08-06
7.4%
6.3% 
Trending screeners:
@electric-vehicles
@saas
@cannabis-players
@china
Latin America
India
Dividends
@REITs
@adtech
@airlines
@artificial-intelligence
@auto-parts
@cloud-computing
@crypto
@cybersecurity
@e-commerce
@edtech
@finance-and-technology
@gaming
@internet-of-things
@oil-refining
@real-estate-tech
@renewable-energy
@vaccine-makers

Reviews

2025-07-30
#reports #XGN

[Exagen](https://eninvs.com/all.php?name=XGN) (Diagnostics and Research) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=189354)
(2025-07-29, Before Market Open):

- Revenue +13.3% YoY (vs +7.1% in previous quarter and historical rate +11.5%)
- EBITDA margin -11.8% increased compared to -13.3% same period last year
- Net Debt decreased by $13 mln over the past reporting period (9.0% of market cap)
- FCF (LTM) -$0 bln (negative), 9.0% of market cap
- EV/Sales multiple is 2.4x

At the opening of the session the share price went up +7.8% vs S&P500 +0.2%
2025-07-30
#reports #VRNS

[Varonis Systems](https://eninvs.com/all.php?name=VRNS) (Software developer) reported for 2025 q2
(2025-07-29, After Market Close):

- Revenue +16.9% YoY (vs +19.3% in previous quarter and historical rate +21.6%)
- EBITDA margin -13.2% increased compared to -14.6% same period last year
- Net Debt decreased by $198 mln over the past reporting period (3.9% of market cap)
- FCF (LTM) -$0.4 bln (negative), 7.9% of market cap
- EV/Sales multiple is 8.5x

At the opening of the session the share price went up +2.7% vs S&P500 +0.2%
2025-07-30
#reports #TRS

[TriMas](https://eninvs.com/all.php?name=TRS) (Engergy services provider) reported for 2025 q2
(2025-07-29, Before Market Open):

- Revenue +14.1% YoY (vs +6.6% in previous quarter and historical rate +3.0%)
- EBITDA +32.1% YoY (vs +40.9% in previous quarter and historical rate -6.3%)
- EBITDA margin 13.5% increased compared to 11.6% same period last year
- Net Debt decreased by $6 mln over the past reporting period (0.4% of market cap)
- FCF (LTM) -$0 bln (negative), 1.0% of market cap
- EV/EBITDA multiple is 16.9x compared to historical level (75th percentile) of 14.7x
- EV/Sales multiple is 2x

At the opening of the session the share price went up +15.9% vs S&P500 +0.2%
2025-07-30
#reports #TDOC

[Teladoc Health](https://eninvs.com/all.php?name=TDOC) (Health care provider) reported for 2025 q2
(2025-07-29, After Market Close):

- Revenue -1.6% YoY (vs -2.6% in previous quarter and historical rate +4.7%)
- EBITDA margin -7.9% increased compared to -130.7% same period last year
- Net Debt decreased by $37 mln over the past reporting period (5.4% of market cap)
- FCF (LTM) +$0 bln (positive), 4.8% of market cap
- EV/Sales multiple is 0.4x

At the opening of the session the share price went up +1.0% vs S&P500 +0.2%
2025-07-30
#reports #STX

[Seagate Technology](https://eninvs.com/all.php?name=STX) (Hard disk drives manufacturer) reported for 2025 q2
(2025-07-29, After Market Close):

- Revenue +29.5% YoY (vs +30.5% in previous quarter and historical rate -2.3%)
- EBITDA +61.8% YoY (vs +87.0% in previous quarter and historical rate +37.2%)
- EBITDA margin 25.8% increased compared to 20.7% same period last year
- Net Debt decreased by $228 mln over the past reporting period (0.7% of market cap)
- EV/EBITDA multiple is 14.6x compared to historical level (75th percentile) of 53x
- EV/Sales multiple is 3.9x

At the opening of the session the share price went down -7.6% vs S&P500 +0.2%
2025-07-30
#reports #SSTK

[Shutterstock](https://eninvs.com/all.php?name=SSTK) (Photo and video sharing platform) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=189350)
(2025-07-29, Before Market Open):

- Revenue +21.4% YoY (vs +13.6% in previous quarter and historical rate +8.0%)
- EBITDA +35.7% YoY (vs -13.2% in previous quarter and historical rate +7.8%)
- EBITDA margin 21.3% increased compared to 19.1% same period last year
- Net Debt decreased by $5 mln over the past reporting period (0.7% of market cap)
- FCF (LTM) +$0 bln (positive), 4.7% of market cap
- EV/EBITDA multiple is 5.4x compared to historical level (75th percentile) of 11.4x
- EV/Sales multiple is 0.9x

At the opening of the session the share price went up +5.1% vs S&P500 +0.2%
2025-07-30
#reports #RMAX

[RE/MAX](https://eninvs.com/all.php?name=RMAX) (Real estate franchise service provider) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=189347)
(2025-07-29, After Market Close):

- Revenue -6.4% YoY (vs -5.1% in previous quarter and historical rate -6.5%)
- EBITDA -12.5% YoY (vs 0.0% in previous quarter and historical rate +30.4%)
- EBITDA margin 28.8% decreased compared to 30.8% same period last year
- Net Debt decreased by $8 mln over the past reporting period (4.9% of market cap)
- FCF (LTM) +$0 bln (positive), 18.3% of market cap
- EV/EBITDA multiple is 0.2x compared to historical level (75th percentile) of 2.5x
- EV/Sales multiple is 0.1x

At the opening of the session the share price went down -4.0% vs S&P500 +0.2%
2025-07-30
#reports #RCL

[Royal Caribbean Cruises](https://eninvs.com/all.php?name=RCL) (Entertainment services provider) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=189346)
(2025-07-29, Before Market Open):

- Revenue +13.1% YoY (vs -35.3% in previous quarter and historical rate +60.0%)
- EBITDA +13.3% YoY (vs -90.3% in previous quarter and historical rate +101.3%)
- EBITDA margin 36.4% has not changed compared to 36.3% same period last year
- Net Debt decreased by $925 mln over the past reporting period (1.1% of market cap)
- FCF (LTM) +$1.6 bln (positive), 1.9% of market cap
- EV/EBITDA multiple is 19.9x compared to historical level (75th percentile) of 17.4x
- EV/Sales multiple is 6.7x

At the opening of the session the share price went down -7.6% vs S&P500 +0.2%
2025-07-30
#reports #RCKY

[Rocky Brands](https://eninvs.com/all.php?name=RCKY) (Footwear and Accessories) reported for 2025 q2
(2025-07-29, After Market Close):

- Revenue +8.2% YoY (vs +0.9% in previous quarter and historical rate -7.9%)
- EBITDA +50% YoY (vs +10.0% in previous quarter and historical rate +24.5%)
- EBITDA margin 8.5% increased compared to 6.1% same period last year
- Net Debt increased by $3 mln over the past reporting period (1.8% of market cap)
- FCF (LTM) +$0 bln (positive), 14.3% of market cap
- EV/EBITDA multiple is 8.2x compared to historical level (75th percentile) of 10.3x
- EV/Sales multiple is 0.6x

At the opening of the session the share price went up +26.4% vs S&P500 +0.2%
2025-07-30
#reports #QRVO

[Qorvo](https://eninvs.com/all.php?name=QRVO) (Analog integrated circuits manufacturer) reported for 2025 q2
(2025-07-29, After Market Close):

- Revenue -7.7% YoY (vs -7.7% in previous quarter and historical rate -2.9%)
- EBITDA +27.3% YoY (vs -4.9% in previous quarter and historical rate +8.3%)
- EBITDA margin 8.5% increased compared to 6.2% same period last year
- Net Debt decreased by $144 mln over the past reporting period (1.8% of market cap)
- FCF (LTM) +$0.2 bln (positive), 2.5% of market cap
- EV/EBITDA multiple is 26.4x compared to historical level (75th percentile) of 44x
- EV/Sales multiple is 2.3x

2025-07-30
#reports #PEN

[Penumbra](https://eninvs.com/all.php?name=PEN) (Medical equipment manufacturer) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=189342)
(2025-07-29, After Market Close):

- Revenue +13.4% YoY (vs +16.1% in previous quarter and historical rate +16.8%)
- EBITDA margin 14.5% increased compared to -24.4% same period last year
- Net Debt decreased by $46 mln over the past reporting period (0.5% of market cap)
- FCF (LTM) +$0.1 bln (positive), 1.1% of market cap
- EV/EBITDA multiple is 54x compared to historical level (75th percentile) of 421.2x
- EV/Sales multiple is 6.7x

At the opening of the session the share price went up +10.7% vs S&P500 +0.2%
2025-07-30
#reports #PEB

[Pebblebrook Hotel Trust](https://eninvs.com/all.php?name=PEB) (REIT — Hotel and Motel) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=189341)
(2025-07-29, After Market Close):

- Revenue +2.8% YoY (vs +1.9% in previous quarter and historical rate +7.6%)
- EBITDA -6.8% YoY (vs -10.7% in previous quarter and historical rate +13.5%)
- EBITDA margin 27.0% decreased compared to 29.7% same period last year
- Net Debt decreased by $56 mln over the past reporting period (4.1% of market cap)
- EV/EBITDA multiple is 12x compared to historical level (75th percentile) of 15.2x
- EV/Sales multiple is 2.4x

At the opening of the session the share price went up +2.3% vs S&P500 +0.2%
2025-07-30
#reports #NEOG

[Neogen](https://eninvs.com/all.php?name=NEOG) (Food testing equipment manufacturer) reported for 2025 q2
(2025-07-29, Before Market Open):

- Revenue -5.1% YoY (vs -3.5% in previous quarter and historical rate +23.7%)
- EBITDA -954.4% YoY (vs +105.9% in previous quarter and historical rate +11.0%)
- EBITDA margin -258.2% decreased compared to 28.7% same period last year
- Net Debt increased by $7 mln over the past reporting period (0.7% of market cap)
- FCF (LTM) -$0 bln (negative), 3.6% of market cap
- EV/Sales multiple is 2x

At the opening of the session the share price went down -8.5% vs S&P500 +0.2%
2025-07-30
#reports #NEO

[NeoGenomics](https://eninvs.com/all.php?name=NEO) (Network of clinical laboratories) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=189338)
(2025-07-29, Before Market Open):

- Revenue +9.7% YoY (vs +7.7% in previous quarter and historical rate +12.2%)
- EBITDA margin -16.6% decreased compared to -2.4% same period last year
- Net Debt increased by $1 mln over the past reporting period (0.1% of market cap)
- FCF (LTM) -$0 bln (negative), 4.2% of market cap
- EV/Sales multiple is 1.3x

At the opening of the session the share price went down -18.0% vs S&P500 +0.2%
2025-07-30
#reports #MDLZ

[Mondelez International](https://eninvs.com/all.php?name=MDLZ) (Food and beverage manufacturer) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=189337)
(2025-07-29, After Market Close):

- Revenue +7.7% YoY (vs +0.2% in previous quarter and historical rate +7.7%)
- EBITDA +49.8% YoY (vs -67.0% in previous quarter and historical rate +14.6%)
- EBITDA margin 19.5% increased compared to 14.0% same period last year
- Net Debt increased by $2.8 bln since the start of the year (2.9% of market cap)
- FCF (LTM) -$1.9 bln (negative), 1.9% of market cap
- EV/EBITDA multiple is 22.2x compared to historical level (75th percentile) of 22.9x
- EV/Sales multiple is 3.7x

2025-07-30
#reports #LXU

[LSB Industries](https://eninvs.com/all.php?name=LXU) (Chemicals) reported for 2025 q2
(2025-07-28, After Market Close):

- Revenue +7.9% YoY (vs +3.6% in previous quarter and historical rate -7.9%)
- EBITDA -28.6% YoY (vs -58.6% in previous quarter and historical rate -43.2%)
- EBITDA margin 13.2% decreased compared to 20.0% same period last year
- Net Debt increased by $6 mln over the past reporting period (0.8% of market cap)
- FCF (LTM) -$0.1 bln (negative), 7.8% of market cap
- EV/Sales multiple is 2.1x

At the opening of the session the share price went up +0.3% vs S&P500 +0.2%
2025-07-30
#reports #LSTR

[Landstar System](https://eninvs.com/all.php?name=LSTR) (Logistic services provider) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=189334)
(2025-07-29, After Market Close):

- Revenue -1.1% YoY (vs -1.5% in previous quarter and historical rate -13.4%)
- EBITDA -18.1% YoY (vs -29.7% in previous quarter and historical rate -10.1%)
- EBITDA margin 5.6% decreased compared to 6.8% same period last year
- Net Debt increased by $38 mln over the past reporting period (0.8% of market cap)
- FCF (LTM) -$0.1 bln (negative), 1.1% of market cap
- EV/EBITDA multiple is 16.8x compared to historical level (75th percentile) of 23x
- EV/Sales multiple is 0.9x

2025-07-30
#reports #LAD

[Lithia Motors](https://eninvs.com/all.php?name=LAD) (Vehicle seller) reported for 2025 q2
(2025-07-29, Before Market Open):

- Revenue +3.8% YoY (vs +7.3% in previous quarter and historical rate +12.3%)
- EBITDA +7.7% YoY (vs +17.8% in previous quarter and historical rate +4.9%)
- EBITDA margin 5.1% increased compared to 4.9% same period last year
- Net Debt increased by $446 mln over the past reporting period (5.3% of market cap)
- FCF (LTM) +$6.7 bln (positive), 80.4% of market cap
- EV/EBITDA multiple is 11.2x compared to historical level (75th percentile) of 14x
- EV/Sales multiple is 0.6x

At the opening of the session the share price went down -1.9% vs S&P500 +0.2%
2025-07-30
#reports #KNSA

[Kiniksa Pharmaceuticals](https://eninvs.com/all.php?name=KNSA) (Biotechnology) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=189307)
(2025-07-29, Before Market Open):

- Revenue +44% YoY (vs +72.5% in previous quarter and historical rate +80.9%)
- EBITDA margin 54.8% increased compared to 0.0% same period last year
- Net Debt decreased by $40 mln over the past reporting period (1.8% of market cap)
- FCF (LTM) +$0 bln (positive), 2.1% of market cap
- EV/EBITDA multiple is 4.6x compared to historical level (75th percentile) of 37.7x
- EV/Sales multiple is 3.5x

At the opening of the session the share price went up +13.2% vs S&P500 +0.2%
2025-07-30
#reports #INCY

[Incyte](https://eninvs.com/all.php?name=INCY) (Small molecule drugs developer) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=189331)
(2025-07-29, Before Market Open):

- Revenue +16.5% YoY (vs +19.5% in previous quarter and historical rate +11.6%)
- EBITDA margin 45.1% increased compared to -44.1% same period last year
- Net Debt decreased by $14 mln over the past reporting period (0.1% of market cap)
- FCF (LTM) +$1 bln (positive), 6.4% of market cap
- EV/EBITDA multiple is 9.8x compared to historical level (75th percentile) of 56.8x
- EV/Sales multiple is 2.7x

At the opening of the session the share price went up +2.6% vs S&P500 +0.2%
2025-07-30
#reports #HUBB

[Hubbell](https://eninvs.com/all.php?name=HUBB) (Electrical and electronic products manufacturer) reported for 2025 q2
(2025-07-29, Before Market Open):

- Revenue +2.1% YoY (vs -2.4% in previous quarter and historical rate +6.1%)
- EBITDA +9.7% YoY (vs -0.7% in previous quarter and historical rate +29.3%)
- EBITDA margin 25.9% increased compared to 24.2% same period last year
- Net Debt decreased by $52 mln over the past reporting period (0.2% of market cap)
- FCF (LTM) +$0.2 bln (positive), 0.7% of market cap
- EV/EBITDA multiple is 18.6x compared to historical level (75th percentile) of 19.6x
- EV/Sales multiple is 4.3x

At the opening of the session the share price went down -3.0% vs S&P500 +0.2%